These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2858762)

  • 1. MPTP-like molecules and Parkinson's disease.
    Fellman JH; Nutt JN
    Lancet; 1985 Apr; 1(8434):924. PubMed ID: 2858762
    [No Abstract]   [Full Text] [Related]  

  • 2. Does an endogenous methylpyridinium analogue cause Parkinson's disease?
    Testa B; Naylor R; Costall B; Jenner P; Marsden CD
    J Pharm Pharmacol; 1985 Sep; 37(9):679-80. PubMed ID: 2867199
    [No Abstract]   [Full Text] [Related]  

  • 3. Selegiline and the prophylaxis of Parkinson's disease.
    Sandler M; Willoughby J; Glover V; Gibb C
    J Neural Transm Suppl; 1987; 25():35-43. PubMed ID: 3123604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): one designer drug and serendipity.
    Weingarten HL
    J Forensic Sci; 1988 Mar; 33(2):588-95. PubMed ID: 3259617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Burns RS; LeWitt PA; Ebert MH; Pakkenberg H; Kopin IJ
    N Engl J Med; 1985 May; 312(22):1418-21. PubMed ID: 2581135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of MAO in MPTP toxicity--a review.
    Glover V; Gibb C; Sandler M
    J Neural Transm Suppl; 1986; 20():65-76. PubMed ID: 3091762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.
    Langston JW; Ballard PA
    N Engl J Med; 1983 Aug; 309(5):310. PubMed ID: 6602944
    [No Abstract]   [Full Text] [Related]  

  • 8. The MPTP tale: pathway to prevention of Parkinson's disease?
    Williams A; Waring R
    Br J Hosp Med; 1993 May 19-Jun 1; 49(10):716-9. PubMed ID: 8324592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The possible relation of glutathione, melanin and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) to Parkinson's disease.
    Bannon MJ; Goedert M; Williams B
    Biochem Pharmacol; 1984 Sep; 33(17):2697-8. PubMed ID: 6331828
    [No Abstract]   [Full Text] [Related]  

  • 10. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P; Marsden CD
    J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [11C]MPTP: a potential tracer for Parkinson's disease research in laboratory animals.
    Livni E; Spellman JP; Correia JA; Alpert NM; Brownell GL; Strauss HW; Elmaleh DR
    J Nucl Med; 1986 Oct; 27(10):1600-3. PubMed ID: 3489823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptides and dopamine in the marmoset. Effect of treatment with 1-methyl-4-phenyl-1, 2, 3, 6 tetrahydropyridine (MPTP): an animal model for Parkinson's disease?
    Allen JM; Cross AJ; Yeats JC; Ghatei MA; McGregor GP; Close SP; Pay S; Marriott AS; Tyers MB; Crow TJ
    Brain; 1986 Feb; 109 ( Pt 1)():143-57. PubMed ID: 2417654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aetiology of Parkinson's disease.
    Bocchetta A; Corsini GU
    Lancet; 1985 Jan; 1(8420):112-3. PubMed ID: 2857013
    [No Abstract]   [Full Text] [Related]  

  • 14. Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases.
    Ballard PA; Tetrud JW; Langston JW
    Neurology; 1985 Jul; 35(7):949-56. PubMed ID: 3874373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methyltetrahydro-beta-carbolines and Parkinson's disease.
    Ohkubo S; Hiraro T; Oka K
    Lancet; 1985 Jun; 1(8440):1272-3. PubMed ID: 2860467
    [No Abstract]   [Full Text] [Related]  

  • 16. MPTP: insights into the etiology of Parkinson's disease.
    Langston JW
    Eur Neurol; 1987; 26 Suppl 1():2-10. PubMed ID: 3556187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MPTP and the aetiology of Parkinson's disease. Clinical implications. London, June 27, 1985.
    J Neural Transm Suppl; 1986; 20():1-81. PubMed ID: 3489069
    [No Abstract]   [Full Text] [Related]  

  • 18. The MPTP model of Parkinson's disease.
    Smeyne RJ; Jackson-Lewis V
    Brain Res Mol Brain Res; 2005 Mar; 134(1):57-66. PubMed ID: 15790530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of induction of parkinsonism by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a dopaminergic neurotoxin].
    Hirata Y; Nagatsu T
    Tanpakushitsu Kakusan Koso; 1986 Apr; 31(5):398-409. PubMed ID: 3520683
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pathogenic substances in Parkinson disease and new therapeutics considering the etiologic mechanism].
    Nagatsu T
    Nihon Rinsho; 1988 Sep; 46(9):2086-97. PubMed ID: 2907356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.